BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32110933)

  • 21. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
    Lu Y; Yu T; Liu J; Gu L
    PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
    Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
    Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green tea polyphenols prevent lipopolysaccharide-induced inflammatory liver injury in mice by inhibiting NLRP3 inflammasome activation.
    Wang D; Zhang M; Wang T; Cai M; Qian F; Sun Y; Wang Y
    Food Funct; 2019 Jul; 10(7):3898-3908. PubMed ID: 31187838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digitoflavone (DG) attenuates LPS-induced acute lung injury through reducing oxidative stress and inflammatory response dependent on the suppression of TXNIP/NLRP3 and NF-κB.
    Meng M
    Biomed Pharmacother; 2017 Oct; 94():712-725. PubMed ID: 28800542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
    Wang C; Zeng L; Zhang T; Liu J; Wang W
    Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time‑dependent changes in NLRP3 and Nrf2 levels in lipopolysaccharide‑induced acute lung injury.
    Dhar R; Li N; Zhang L; Li Y; Rana MN; Cao X; Hu Z; Wang X; Zheng X; Xu X; Tang H
    Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36321790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis.
    Lv H; Liu Q; Wen Z; Feng H; Deng X; Ci X
    Redox Biol; 2017 Aug; 12():311-324. PubMed ID: 28285192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eriodictyol ameliorates lipopolysaccharide-induced acute lung injury by suppressing the inflammatory COX-2/NLRP3/NF-κB pathway in mice.
    Wang X; Deng R; Dong J; Huang L; Li J; Zhang B
    J Biochem Mol Toxicol; 2020 Mar; 34(3):e22434. PubMed ID: 31860763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malvidin protects against lipopolysaccharide-induced acute liver injury in mice via regulating Nrf2 and NLRP3 pathways and suppressing apoptosis and autophagy.
    Fan H; Cui J; Liu F; Zhang W; Yang H; He N; Dong Z; Dong J
    Eur J Pharmacol; 2022 Oct; 933():175252. PubMed ID: 36063870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 4B is required for NLRP3 inflammasome activation by positive feedback with Nrf2 in the early phase of LPS- induced acute lung injury.
    Dhar R; Rana MN; Zhang L; Li Y; Li N; Hu Z; Yan C; Wang X; Zheng X; Liu H; Cui H; Li Z; Tang H
    Free Radic Biol Med; 2021 Nov; 176():378-391. PubMed ID: 34644617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway.
    Hong H; Lou S; Zheng F; Gao H; Wang N; Tian S; Huang G; Zhao H
    Phytomedicine; 2022 Jul; 101():154143. PubMed ID: 35537248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation.
    Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F
    Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
    Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
    Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway.
    Zeng J; Chen Y; Ding R; Feng L; Fu Z; Yang S; Deng X; Xie Z; Zheng S
    J Neuroinflammation; 2017 Jun; 14(1):119. PubMed ID: 28610608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
    Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
    Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.